RSSMicro.com Search - RSS Feed Search Engine - RSS Feed Directory
Dedicated RSS Feed Search Engine
 Search 4.3 million RSS feeds
The most comprehensive RSS feed search on the web
Top Stories  |  FeedRank Checker

Published

   Last Hour

   Last Day

   Past Week

   Past Month

 Anytime







Featured
RSS Feeds


CNN RSS Feeds

Reuters RSS Feeds

MSNBC RSS Feeds

New York Times RSS Feeds

Washington Post RSS Feeds

CNBC RSS Feeds

ABC News RSS Feeds

Fox News RSS Feeds

Sky News RSS Feeds

Forbes RSS Feeds

CNET RSS Feeds

Unicef RSS Feeds

PBS RSS Feeds

Wall Street Journal RSS Feeds

Financial Times RSS Feeds

Business Week RSS Feeds

Bloomberg RSS Feeds

TheStreet RSS Feeds

ESPN RSS Feeds

   




FeedRank - RSSMicro Search

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more


NCBI PubMed


FeedRank: 8/10  8/10  Excellent  ---  eutils.ncbi.nlm.nih.gov
NCBI: db=PubMed; Term=radiotherapy OR ("radiation therapy") ...

 

 
Saturday, October 11, 2008 --- 38 days ago
Related Articles WITHDRAWN: Interventions for early stage Hodgkin's disease in children. Cochrane Database Syst Rev. 2008;(4):CD002035 Authors: Louw GG, Pinkerton CR BACKGROUND: Hodgkin's disease is one of the most curable cancers in children, particularly at the early stages. However it is not clear which combinations of treatment strategies are most effective at maintaining high cure rates and minimising long term harmful effects or sequelae of treatment. OBJECTIVES: To assess the effects of radiotherapy, chemotherapy or combined radiotherapy and chemotherapy on relapse free survival and overall survival rates in children with early (stage I to IIA) Hodgkin's disease. SEARCH STRATEGY: We searched the Cochrane Library (issue 4, 2001), MEDLINE (1966 to July 2001), EMBASE, Cinahl, Cancer-CD and reference lists of relevant articles. We also handsearched six journals. SELECTION CRITERIA: Randomised controlled trials of involved field radiotherapy, extended field radiotherapy, anthracycline based chemotherapy regimens, or alkylating chemotherapy agents in children to 19 years of age with Hodgkin's disease. DATA COLLECTION AND ANALYSIS: Trial eligibility and quality were assessed and study authors were contacted for additional information. MAIN RESULTS: Four trials involving 334 children were included. It was not possible to combine the outcomes as they covered different treatment regimens. The trials were of variable quality. One trial co ...




Recent Posts





 Facebook     Del.icio.us     Digg     StumbleUpon     Reddit     Google
Copyright © 2008 RSSMicro.com